Efficacy results from a multicenter phase II noncomparative two-arm pilot trial of bevacizumab with anastrozole or fulvestrant as first-line endocrine therapy for metastatic breast cancer No ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results